The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.00
Bid: 359.00
Ask: 359.80
Change: 0.00 (0.00%)
Spread: 0.80 (0.223%)
Open: 357.80
High: 0.00
Low: 0.00
Prev. Close: 360.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter Trading Update

21 Jul 2022 07:00

RNS Number : 2149T
QinetiQ Group plc
21 July 2022
 

News release

QinetiQ Group plc

First Quarter Trading Update

21 July 2022 - QinetiQ Group plc ("QinetiQ" or "the Group") today issues a trading update covering its first quarter of trading.

Strong first quarter performance

Building on the second half momentum of FY22, we have made a good start to FY23 with strong group operational performance. Order intake has continued to remain strong and revenue, profit and cash are in-line with expectations. Our visibility on revenue under contract for FY23 has increased to £1.05bn, up from £900m at April 2022. Consequently, we remain confident of delivering in-line with our expectations, with mid-single digit organic revenue growth and operating profit towards the mid-point of our 11% to 12% short-term operating profit margin target, rising to 12% to 13% operating profit margin in the medium term.

Recent world events have reinforced the long-term needs of our customers, including capabilities utilising differentiated technology, alongside test and training solutions that are directly aligned with our strategy. In all of the markets in which we operate globally Governments are seeking to enhance their defence and security stance against the evolving future threats, with rising defence spending in all of our three home countries: UK, US and Australia. More significantly still, our six distinctive offerings are well aligned with segments of the defence budgets that are priorities to combat future threats.

We have seen a strong start to the year in EMEA Services and continued good progress in the US and other areas of Global Products. Overall, the Group is showing continued growth and profitability in-line with our expectations, both in the short and medium term.

Strategy Update

Our strategy to build an integrated global defence and security company with revenues of more than £2.3bn is continuing to deliver. Building on our successful six year track record of growth, we are continuing to deliver for our customers and on our promises. We remain focussed on our six distinctive offerings, with a particular focus on growth in the UK, US and Australia. We remain active in driving both strong organic growth as well as executing on our inorganic growth strategy. In the first quarter, we achieved a number of successes that demonstrate our delivery on strategic objectives:

SPUR robot deliveries - our US business has achieved a major production milestone with the completion of the Low-Rate Production (LRIP) contract of the Common Robotic System Individual (CRS-I) for the US Army. We are also progressing with our production ramp-up for the $64m Full-Rate Production (FRP) contract which we won last year; the largest Program of Record for US Robotics for the delivery of a further 1,200 SPUR robots.

Bradley electric drive - in August 2020, we announced our joint win with BAE Systems in the US where we successfully bid into the Rapid Capabilities and Critical Technologies Office (RCCTO) to integrate our E-X-Drive hybrid propulsion system into their Bradley Fighting Vehicle. After a successful delivery programme, we have now completed one of the final milestones of that project where the vehicle has been successfully tested in the US in collaboration with the RCCTO.

Engineering Delivery Partner (EDP) passes £1bn orders - our EDP programme has continued to deliver growth through Q1 with total contract orders now surpassing £1bn since inception in October 2018. Operational performance remains strong with EDP assessed by the UK MOD as delivering good value for money. This test was a key part of successfully passing the four-year review - providing further confidence in our service quality and as an enabler for essential UK defence capabilities.

£19m artificial intelligence (AI) cyber defence win - we have won a £19m contract to support UK's DSTL project called Autonomous Resilient Cyber Defence (ARCD) - a multi-year programme to develop and demonstrate self-defending and self-recovering concepts for military platforms and networks in the face of increasingly complex cyber-attacks. Ensuring that tanks, aircraft and ships can automatically identify and defend themselves against a Cyber attack reduces the need for human intervention and provides a quicker response time, thereby reducing the risk of the platform being compromised and ultimately protecting the sailors, airmen and soldiers who use them.

Global leverage of Test & Evaluation (T&E) capability - our Sovereign T&E Skills programme has launched and is making good progress by leveraging our UK capabilities to grow sovereign T&E capability in Australia and Canada. By accessing the unique knowledge and experience of our T&E subject-matter experts, we are offering a tailorable, holistic learning programme designed to build sovereign skills and capabilities to support customers in delivering complex T&E outcomes. The programme blends formal, social and experiential learning which is defence standards-based, quality-assured, and provides measurable progress towards a defined outcome set.

50% flying hours increase in Germany - we are seeing continued demand for the services delivered by our German business with flying hours for our Bundeswehr customers, a key performance metric, now 50% higher than in 2019. Allied to these higher levels of service provision, we have recently secured an €18m contract to continue our core deliveries over the next 12 months.

Net-Zero plan verification - first company in the A&D sector and one of the first 20 companies globally to have our Net-Zero plan verified by the Science Based Targets Initiative (SBTi). Our Net-Zero Plan includes 2030 and long-term Net-Zero science-based GHG emissions reductions targets, which are aligned with the 1.5°c pathway. They are based on a planned programme of activities, applying a data-driven approach to inform what we do and when. We developed these in accordance with the SBTi Net-Zero Standard and criteria and the associated GHG Protocol Corporate Standards. In June 2022 the SBTi verified our near and long-term Net-Zero science-based targets. We are also delighted to be part of the Business Ambition for 1.5°c campaign, which is part of the UN-backed Race to Zero.

AGM

QinetiQ's 2022 Annual General Meeting (AGM) will be held at 11am today at Ashurst LLP, London Fruit & Wool Exchange, 1 Duval Square, London E1 6PW.

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Lorna Cobbett, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7771 344781

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKBLFLLDLZBBX
Date   Source Headline
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding
16th Nov 202111:24 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.